Table 5 Relative risk of second primary cancer for any first primary cancer by type of second primary cancer and sex

Oral Cavity & Pharynx

1136

449.60

2.53

(2.38–2.68)

429

189.05

2.27

(2.05–2.49)

Oesophagus

566

293.21

1.93

(1.76–2.10)

219

96.60

2.27

(1.95–2.59)

Stomach

670

528.41

1.27

(1.17–1.37)

386

299.80

1.29

(1.15–1.42)

Colorectal

2430

2066.81

1.18

(1.13–1.22)

1923

1470.15

1.31

(1.25–1.37)

Liver & Intrahepatic Bile Ducts

576

453.56

1.27

(1.16–1.38)

192

137.66

1.39

(1.19–1.60)

Pancreas

669

490.60

1.36

(1.26–1.47)

598

469.70

1.27

(1.17–1.38)

Larynx

317

179.31

1.77

(1.56–1.97)

50

26.04

1.92

(1.31–5.53)

Lung

3551

2262.39

1.57

(1.52–1.62)

1601

891.66

1.80

(1.71–1.88)

Skin Melanoma

926

670.74

1.38

(1.29–1.47)

736

513.03

1.43

(1.33–1.54)

Breast female

–

–

–

–

2597

3515.70

0.74

(0.71–0.77)

Cervix Uteri

–

–

–

–

125

152.49

0.82

(0.66–0.98)

Corpus Uteri & NOS

–

–

–

–

876

674.95

1.30

(1.21–1.39)

Ovary

–

–

–

–

530

437.46

1.21

(1.10–1.32)

Prostate

3694

5486.76

0.67

(0.65–0.70)

–

–

–

–

Testis

36

49.08

0.73

(0.45–1.02)

–

–

–

–

Kidney

537

396.46

1.35

(1.23–1.47)

275

196.64

1.40

(1.22–1.57)

Bladder

1053

855.25

1.23

(1.16–1.31)

334

238.59

1.40

(1.24–1.56)

Brain & Central Nerves

242

184.26

1.31

(1.14–1.49)

161

139.94

1.15

(0.96–1.34)

Thyroid

143

60.76

2.35

(1.93–2.77)

271

156.18

1.74

(1.52–1.95)

Hodgkin Lymphoma

67

39.21

1.71

(1.25–2.17)

56

28.16

1.99

(1.39–2.58)

Non Hodgkin Lymphoma

733

539.77

1.36

(1.26–1.46)

568

440.42

1.29

(1.18–1.40)

Multiple Myeloma

291

231.10

1.26

(1.11–1.41)

196

188.29

1.04

(0.88–1.20)

Leukaemia

590

428.02

1.38

(1.26–1.49)

472

283.12

1.67

(1.51–1.82)

All Cancers

18,811

16,827.19

1.18

(1.16–1.19)

13,982

11,631.97

1.20

(1.18–1.22)